Eli Lilly booth at AACR 2026
Biotech

Lilly inks deals to buy 3 vaccine developers for up to $3.8B

Lilly is acquiring Curevo, LimmaTech and Vaccine Company to extend its shopping spree into viral and bacterial pathogen R&D.
Nick Paul Taylor May 26, 2026 7:57am
Astellas

Astellas targets more deals, cost cutting to swerve patent cliff

May 26, 2026 7:35am
Cholesterol particles in blood vessel among red blood cells

Lilly preps gene editor for ph. 2 after strong cholesterol cuts

May 25, 2026 8:45am
Martin Makary FDA Senate HELP confirmation

Makary FDA reforms ‘continue to move forward’ despite turmoil

May 26, 2026 10:27am
Combine

Kura posts data on drug designed to unleash KRAS inhibitors

May 26, 2026 10:09am
Top drug launches of 2026

BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions

May 22, 2026 10:00am
More News

Former FDA leader takes new biotech Turn—Chutes & Ladders

May 22, 2026 8:30am

Has Novartis’ T-Charge push been overtaken by in vivo CAR-Ts?

May 22, 2026 8:28am

OSE turns up the heat on ovarian cancer with phase 2 win

May 22, 2026 7:14am

Biogen axes Denali-partnered Parkinson’s drug after phase 2 flop

May 22, 2026 6:12am